Patents
Literature
Hiro is an intelligent assistant for R&D personnel, combined with Patent DNA, to facilitate innovative research.
Hiro

8 results about "Methylation" patented technology

In the chemical sciences, methylation denotes the addition of a methyl group on a substrate, or the substitution of an atom (or group) by a methyl group. Methylation is a form of alkylation, with a methyl group, rather than a larger carbon chain, replacing a hydrogen atom. These terms are commonly used in chemistry, biochemistry, soil science, and the biological sciences.

Synthetic method for bifenazate

ActiveCN109988084AEfficient removalHigh purityOrganic chemistryHydrazine compoundNitration
The invention relates to a synthetic method for bifenazate. The method comprises the following specific synthetic sections: step 1, performing nitration: mixing a 4-hydroxybiphenyl solution and a toluene solution under stirring for a reaction, and adding a HNO3 solution dropwise for a reaction to obtain a nitration reaction solution; step 2, performing methylation: mixing the nitration reaction solution and anhydrous sodium carbonate powder for a reaction, and adding a dimethyl carbonate solution dropwise for a reaction to obtain a methylation reaction solution; step 3, performing hydrogenation: throwing the methylation reaction solution, hydrogen gas, and Raney nickel into a reaction kettle for a reaction to obtain a hydrogenation reaction liquid; step 4, performing hydrazination: performing a primary hydrazination reaction, performing a secondary hydrazination reaction, performing filter pressing, performing a tertiary hydrazination reaction, and performing secondary filter pressingto obtain a condensation reaction liquid; step 5, performing condensation: mixing a third hydrazine compound, an ethyl acetate solution and an isopropyl chloroformate solution for a reaction to obtaina bifenazate mixed liquid; and step 6, performing purification: performing desolvation, performing crystallization, performing centrifugation, performing washing, performing secondary centrifugation,and performing drying to obtain the finished bifenazate. The method provided by the invention has the effect of improving purity of the bifenazate product.
Owner:绍兴上虞新银邦生化有限公司

The kit for screening colorectal cancer and advanced adenoma and its application

PendingUS20210207221A1High sensitivityStrong specificityMicrobiological testing/measurementBiological testingColon rectal cancerDiagnostic Specificity
The present inventions provides combinations of primers and probes for performing quantitative PCRs that can be used to determine the methylation state and level of BMP3 gene and NDRG4 genes in a patient in need thereof, which leads to surprisingly high diagnostic specificity and sensitivity for diagnosing the presence or the absence of colorectal cancer (CRC) and / or advanced adenoma (AA) in a patient in need therefore. Compositions and methods for performing the diagnosis are provided.
Owner:HANGZHOU NEW HORIZON HEALTH TECH CO LTD

Biomarker combination for early screening of esophageal cancer, kit and application

The invention relates to the technical field of molecular biology, and in particular, relates to a biomarker combination for early screening of esophageal cancer, a kit and application, wherein the biomarker combination comprises four pairs of target specific primers, four specific primer probes, corresponding internal reference primers and internal reference primer probes which are related to early methylation sites of esophageal cancer people. Compared with the prior art, a plurality of pairs of PCR primers are designed by screening esophageal cancer early genome hypermethylation regions of Chinese population and selecting an interval containing at least two sites in CCGC, CCGG, GCGC, ACGT and GCGG as a target spot aiming at the regions; finally, four pairs of primers and corresponding probe sequences which can distinguish tumor tissues from normal tissues under the assistance of methylation-sensitive incision enzyme and are high in PCR efficiency, strong in specificity and good in stability are screened out, the early esophageal cancer detection rate is increased, the esophageal cancer treatment effect is improved, and the esophageal cancer death rate is reduced.
Owner:HANGZHOU QIUZHEN MEDICAL LAB CO LTD
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products